Enalapril formulations | Patent Number 11141405

US 11141405 B2
Application Number17228024
Publication NumberUS 20210251956 A1
Pendency6 months, 3 days
Filled DateApr 12, 2021
Priority DateMar 18, 2016
Publication DateAug 19, 2021
Expiration DateMar 17, 2036
Inventor/ApplicantsDavid W. Miles
Gerold L. Mosher
ExaminesRAO, SAVITHA M
Art Unit1629
Technology Center1600
Assignments
Jpmorgan Chase Bank
Current
Azurity Pharmaceuticals Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.